HighTower Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$289M Buy
820,320
+33,696
+4% +$12M 0.31% 61
2025
Q4
$257M Sell
786,624
-2,753
-0.3% -$873K 0.28% 70
2025
Q3
$223M Buy
789,377
+36,897
+5% +$10.7M 0.25% 79
2025
Q2
$210M Buy
752,480
+24,505
+3% +$6.94M 0.26% 80
2025
Q1
$227M Buy
727,975
+18,954
+3% +$5.6M 0.31% 65
2024
Q4
$185M Buy
709,021
+5,414
+0.8% +$1.61M 0.25% 82
2024
Q3
$227M Buy
703,607
+69,863
+11% +$22.9M 0.32% 62
2024
Q2
$198M Buy
633,744
+20,484
+3% +$6.02M 0.31% 64
2024
Q1
$174M Sell
613,260
-74,617
-11% -$21.8M 0.28% 74
2023
Q4
$198M Buy
687,877
+25,840
+4% +$7.04M 0.33% 60
2023
Q3
$178M Sell
662,037
-179
-0% -$44.7K 0.33% 60
2023
Q2
$147M Buy
662,216
+27,880
+4% +$6.47M 0.29% 71
2023
Q1
$153M Buy
634,336
+54,770
+9% +$13.4M 0.33% 60
2022
Q4
$152M Buy
579,566
+6,986
+1% +$1.87M 0.35% 57
2022
Q3
$129M Buy
572,580
+16,277
+3% +$3.95M 0.35% 57
2022
Q2
$135M Buy
556,303
+767
+0.1% +$188K 0.35% 58
2022
Q1
$134M Buy
555,536
+33,648
+6% +$7.73M 0.3% 71
2021
Q4
$117M Buy
521,888
+1,775
+0.3% +$375K 0.26% 89
2021
Q3
$111M Buy
520,113
+34,839
+7% +$8.02M 0.3% 69
2021
Q2
$118M Buy
485,274
+45,869
+10% +$11.3M 0.34% 59
2021
Q1
$109M Sell
439,405
-3,733
-0.8% -$891K 0.34% 61
2020
Q4
$102M Buy
443,138
+27,429
+7% +$6.32M 0.42% 43
2020
Q3
$106M Sell
415,709
-970
-0.2% -$240K 0.51% 34
2020
Q2
$98.3M Sell
416,679
-2,218
-0.5% -$506K 0.54% 34
2020
Q1
$84.8M Buy
+418,897
New +$91.5M 0.55% 30
2019
Q4
Sell
-439,325
Closed -$85.1M 2318
2019
Q3
$85.1M Sell
439,325
-1,639
-0.4% -$315K 0.46% 40
2019
Q2
$81.3M Buy
440,964
+10,340
+2% +$1.85M 0.48% 37
2019
Q1
$81.8M Sell
430,624
-45,385
-10% -$8.67M 0.55% 28
2018
Q4
$92.8M Sell
476,009
-9,768
-2% -$1.91M 0.71% 21
2018
Q3
$101M Buy
485,777
+13,557
+3% +$2.67M 0.72% 19
2018
Q2
$87.2M Buy
472,220
+16,970
+4% +$3M 0.68% 21
2018
Q1
$77.6M Buy
455,250
+79,906
+21% +$14.7M 0.65% 21
2017
Q4
$65.2M Sell
375,344
-15,514
-4% -$2.75M 0.54% 35
2017
Q3
$72.9M Buy
390,858
+33,105
+9% +$5.87M 0.62% 22
2017
Q2
$61.6M Buy
357,753
+36,988
+12% +$6.02M 0.55% 30
2017
Q1
$52.6M Buy
320,765
+56,851
+22% +$9.45M 0.5% 35
2016
Q4
$38.5M Sell
263,914
-18,125
-6% -$2.73M 0.42% 42
2016
Q3
$47.2M Buy
282,039
+50,350
+22% +$8.51M 0.55% 30
2016
Q2
$35.3M Buy
231,689
+3,713
+2% +$577K 0.45% 38
2016
Q1
$34M Buy
227,976
+31,865
+16% +$4.73M 0.11% 58
2015
Q4
$31.8M Buy
196,111
+28,694
+17% +$4.51M 0.38% 47
2015
Q3
$23.2M Buy
+167,417
New +$26.4M 0.31% 71
2015
Q2
Sell
-86,528
Closed -$13.8M 1534
2015
Q1
$13.8M Buy
86,528
+3,619
+4% +$570K 0.21% 106
2014
Q4
$13.2M Buy
82,909
+16,601
+25% +$2.59M 0.2% 111
2014
Q3
$9.31M Buy
66,308
+10,541
+19% +$1.38M 0.16% 144
2014
Q2
$6.6M Buy
55,767
+696
+1% +$80.6K 0.11% 198
2014
Q1
$6.79M Sell
55,071
-12,117
-18% -$1.47M 0.13% 179
2013
Q4
$7.67M Sell
67,188
-20,036
-23% -$2.28M 0.16% 152
2013
Q3
$9.76M Buy
87,224
+16,092
+23% +$1.74M 0.24% 93
2013
Q2
$7.02M Buy
+71,132
New +$7.38M 0.19% 123

Other funds holding AMGN

HighTower Advisors's AMGN Position: Q1 2026 in Review

HighTower Advisors increased its Amgen (AMGN) stake by 4.3% in Q1 2026, buying an estimated $12M and bringing the position to 820,320 shares worth $289M. The position accounts for 0.31% of the portfolio, ranked #61.

HighTower Advisors first reported a position in AMGN in Q2 2013 and has held it in 50 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • HighTower Advisors held 820,320 shares of Amgen worth $289M as of Q1 2026.
  • HighTower Advisors bought 33,696 Amgen shares in Q1 2026, an estimated $12M.
  • Amgen made up 0.31% of HighTower Advisors's portfolio in Q1 2026, its #61 holding.
  • HighTower Advisors first reported a position in Amgen in Q2 2013 and has held it in 50 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.